Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 47

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 47
---
SARS-CoV). Our business could be materially and adversely affected in the event that the slowdown or suspension in business operations due to any outbreaks carries for a long period of time.

<div align='center'>25</div>

Similarly, natural disasters, wars (including the potential of war), terrorist activity (including threats of terrorist activity), social unrest and heightened travel security measures instituted in response, and travel-related accidents, as well as geopolitical uncertainty and international conflict, will affect overall economic environment and may in turn have a material adverse effect on our business and results of operations. In addition, we may not be adequately prepared in contingency planning or recovery capability in relation to a major incident or crisis, and as a result, our operational continuity may be adversely and materially affected, which in turn may harm our reputation.

Risks Related to Our Corporate Structure

Our directors and officers and Class B Shareholders currently control a significant percentage of the total voting power of our outstanding Ordinary Shares, and they collectively are able to decide matters that require votes of shareholders.

As
of the date of this prospectus, our directors and officers and Class B shareholders collectively
own an aggregate of 95.83% of the total voting power of our outstanding Ordinary Shares.
Mr. Ka Lun To, our Chairman and Chief Executive Officer, through his holding company, has
beneficial ownership and control over 4,680,000 Class A Ordinary Shares and 520,000 Class
B Ordinary Shares, representing approximately 52% of our total voting power of our outstanding
Ordinary Shares, and Qingtian Holdings Ltd., the other Class B shareholder, holds 2,820,000
Class A Ordinary Shares and 480,000 Class B Ordinary Shares, representing approximately 41.75%
of our total voting power. See “Principal Shareholder” on page 100 of
this prospectus for details. Immediately after the completion of the offering, our directors
and officers and Class B shareholders will collectively control an aggregate of 91.09% of
the total voting power of our outstanding Ordinary Shares, and Mr. To will be beneficially
interested in an aggregate of 49.43 % of the total voting power of our outstanding Ordinary
Shares. Immediately after the completion of this offering, assuming the underwriters do not
exercise their over-allotment option, our Class B shareholders, consisting of LTO Holdings
Ltd., wholly owned by Mr. To, and Qingtian Holdings Ltd. will own an aggregate of 89.11%
of our